ABEO — Abeona Therapeutics Share News
0.000.00%
Last trade - 00:00- $260.76m
- $128.92m
- $5.82m
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
Abeona Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Abeona Therapeutics falls after quarterly loss, revenue miss
Abeona Therapeutics Q2 net loss widens, misses analyst expectations
Abeona Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Abeona Therapeutics Holds Pre-IND Meeting With FDA For ABO-701 In Prostate Cancer - SEC Filing
Abeona Therapeutics posts smaller-than-expected Q1 loss per share
Brief: Abeona Therapeutics® Announces Activation Of Children's Hospital Of Philadelphia As A New Qualified Treatment Center For Zevaskyn®
Abeona rises after adding New York treatment center for gene therapy
Abeona Therapeutics 2025 net income slightly misses estimates on higher SG&A costs
Brief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Abeona Therapeutics Names Mohamad Tabrizi as Chief Business Officer
Brief: Abeona Announces Employee Inducement Grants Under Nasdaq Rule
Abeona Therapeutics Q3 profit beats analyst expectations
Brief: Abeona Therapeutics Announces Permanent J-Code For Zevaskyn(Prademagene Zamikeracel)